Virzì Valentina, Ognibene Noemi Maria Giovanna, Sciortino Antonio Salvatore, Culmone Glenda, Virzì Giuseppe
Department of Radiology, "Regina Pacis" Clinic, via Principe Lanza di Scalea 3/5, 93017, San Cataldo, CL, Italy.
Department of Surgery, "Regina Pacis" Clinic, via Principe Lanza di Scalea 3/5, 93017, San Cataldo, CL, Italy.
Insights Imaging. 2018 Oct;9(5):653-659. doi: 10.1007/s13244-018-0640-3. Epub 2018 Jul 5.
To assess the frequency of choledocolithiasis and the role of preoperative laboratory findings, ultrasound (US) and magnetic resonance cholangio-pancreatography (MRCP) in the detection of choledocolithiasis in patients with gallbladder stones awaiting cholecystectomy.
A consecutive sample of 104 patients underwent MRCP prior to cholecystectomy. The patients were classified into different groups on the basis of the risk of choledocolithiasis. A specialised doctor with more 10 years of experience performed the US interpretation and a radiologist performed the MRCP interpretation blinded to US or aspartate aminotransferase (AST)/alanine aminotransferase (ALT)/alkaline phosphatase (ALP) results. A chi-square (χ) test was performed to assess the statistical significance of differences in the frequency of choledocolithiasis based on laboratory findings, choledocal diameter on US and group risk.
MRCP showed calculi in 7 out of 104 patients (6.7%), with no statistically significant differences between the high/moderate risk and low/no risk groups and between the patients with normal and altered laboratory findings or choledocal diameter on preoperative US. The sensitivity and specificity of AST/ALT [positive predictive value (PPV): 12%; negative predictive value (NPV): 94%], ALP (PPV: 7%; NPV: 94%), total serum bilirubin (PPV: 6%; NPV: 93%) and choledocal diameter (PPV: 20%; NPV: 94%) were, respectively, 28.6 and 94.8%, 85.7 and 17.5%, 14.3 and 93.8%, and 14.3 and 95.9%.
MRCP is a reliable evaluation for the detection of common bile duct (CBD) stones, reducing the misdiagnosis of retained choledocholithiasis with normal biochemical predictors and US examination.
• MRCP is a non-invasive method for the detection of CBD stones. • Preoperative MRCP reduces the misdiagnosis of retained choledocholithiasis. • Detection of choledocholithiasis is mandatory prior to cholecystectomy to avoid surgical morbidity.
评估胆总管结石的发生率,以及术前实验室检查结果、超声(US)和磁共振胰胆管造影(MRCP)在等待胆囊切除术的胆囊结石患者中检测胆总管结石的作用。
连续选取104例患者在胆囊切除术前接受MRCP检查。根据胆总管结石风险将患者分为不同组。由一位经验超过10年的专科医生进行US解读,一位放射科医生在不知US或天冬氨酸转氨酶(AST)/丙氨酸转氨酶(ALT)/碱性磷酸酶(ALP)结果的情况下进行MRCP解读。采用卡方(χ)检验评估基于实验室检查结果、US测得的胆总管直径和分组风险的胆总管结石发生率差异的统计学意义。
MRCP显示104例患者中有7例(6.7%)存在结石,高/中度风险组与低/无风险组之间,以及术前US检查时实验室检查结果和胆总管直径正常与异常的患者之间,差异均无统计学意义。AST/ALT[阳性预测值(PPV):12%;阴性预测值(NPV):94%]、ALP(PPV:7%;NPV:94%)、总血清胆红素(PPV:6%;NPV:93%)和胆总管直径(PPV:20%;NPV:94%)的敏感性和特异性分别为28.6%和94.8%、85.7%和17.5%、14.3%和93.8%、14.3%和95.9%。
MRCP是检测胆总管(CBD)结石的可靠评估方法,可减少正常生化指标预测值和US检查时胆总管结石残留的误诊。
• MRCP是检测CBD结石的非侵入性方法。• 术前MRCP可减少胆总管结石残留的误诊。• 胆囊切除术前必须检测胆总管结石以避免手术并发症。